Ningxia Building Materials Group Co Ltd

Ningxia Building Materials opened limit down, trading at 13.95 yuan per share with a market cap of about 6.671 billion yuan. The company's actual controller China National Building Material Group and controlling shareholder China National Building Material Company plan to extend the fulfillment period for their commitment to resolve horizontal competition to within two years from the date the relevant proposal is approved by the shareholders' meeting. Meanwhile, the company launched a buyback plan, intending to spend 100 million to 200 million yuan to repurchase shares at a price cap of 19.47 yuan per share, with the repurchased shares to be cancelled. Previously, from July 22 to August 7, the company's share price had surged over 40 percent cumulatively, and on August 7, when it hit the daily limit up, the trading volume reached 492 million yuan.

Talkweb Information System released its 2026 semi-annual report, achieving operating revenue of 1.312 billion yuan, up 0.39% year-on-year, with net profit attributable to shareholders of the listed company at 69.222 million yuan, down 12.16% year-on-year. The company plans to distribute a cash dividend of 0.25 yuan for every 10 shares to all shareholders. As of the end of the reporting period, the company had over 30 products certified through OpenHarmony compatibility assessment, with related products in the market expansion and application stage. In other news, WuXi AppTec announced that a U.S. court has granted its preliminary injunction motion, shielding the company from immediate adverse impact while it challenges the U.S. Department of Defense's 1260H designation in judicial proceedings. Gaozheng Explosives' controlling shareholder is set to change to Tibet Geology and Mineral Resources Group. Ningxia Building Materials plans to repurchase shares worth 100 million to 200 million yuan for cancellation. Wuhan P&S Information Technology saw semi-annual net profit surge 209.5% year-on-year. Galaxy Microelectronics' semi-annual net profit rose 77.28% year-on-year. Hongte Technology plans to raise no more than 650 million yuan through a rights issue for its Thailand base and other projects. Tuoxin Pharmaceutical plans to raise no more than 228 million yuan through a private placement of shares. Biolight has terminated the planned change of control, and its shares and convertible bonds will resume trading on August 10. Huadong Medicine's wholly-owned subsidiary obtained EU MDR CE certification for its medical aesthetics product. Jumpcan Pharmaceutical's subsidiary obtained drug registration certificates for pediatric laxative granules and mesalazine sustained-release granules. Chinese Health's wholly-owned subsidiary had its drug registration application for ferrous succinate tablets accepted.